JP2018536170A5 - - Google Patents

Download PDF

Info

Publication number
JP2018536170A5
JP2018536170A5 JP2018532841A JP2018532841A JP2018536170A5 JP 2018536170 A5 JP2018536170 A5 JP 2018536170A5 JP 2018532841 A JP2018532841 A JP 2018532841A JP 2018532841 A JP2018532841 A JP 2018532841A JP 2018536170 A5 JP2018536170 A5 JP 2018536170A5
Authority
JP
Japan
Prior art keywords
plgf
sflt
plap
blood glucose
subject
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2018532841A
Other languages
English (en)
Japanese (ja)
Other versions
JP2018536170A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IB2016/055426 external-priority patent/WO2017042751A1/en
Publication of JP2018536170A publication Critical patent/JP2018536170A/ja
Publication of JP2018536170A5 publication Critical patent/JP2018536170A5/ja
Pending legal-status Critical Current

Links

JP2018532841A 2015-09-11 2016-09-12 妊娠関連疾患を同定するin vitro方法 Pending JP2018536170A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201562217270P 2015-09-11 2015-09-11
US62/217,270 2015-09-11
EP16161490 2016-03-21
EP16161490.4 2016-03-21
PCT/IB2016/055426 WO2017042751A1 (en) 2015-09-11 2016-09-12 In vitro method for identifying a pregnancy related disease

Publications (2)

Publication Number Publication Date
JP2018536170A JP2018536170A (ja) 2018-12-06
JP2018536170A5 true JP2018536170A5 (enExample) 2019-10-24

Family

ID=55646323

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2018532841A Pending JP2018536170A (ja) 2015-09-11 2016-09-12 妊娠関連疾患を同定するin vitro方法

Country Status (7)

Country Link
US (1) US11009512B2 (enExample)
EP (2) EP3502705B1 (enExample)
JP (1) JP2018536170A (enExample)
CN (1) CN108700591A (enExample)
AU (1) AU2016319010A1 (enExample)
CA (1) CA2998275A1 (enExample)
WO (1) WO2017042751A1 (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20200109293A (ko) 2017-09-13 2020-09-22 프로제너티, 인크. 자간전증 바이오마커 및 관련된 시스템 및 방법
GB2615975B (en) * 2019-02-14 2023-11-29 Mirvie Inc Methods and systems for determining a pregnancy-related state of a subject
WO2021113710A1 (en) 2019-12-04 2021-06-10 Progenity, Inc. Assessment of preeclampsia using assays for free and dissociated placental growth factor
CN113308533B (zh) * 2021-05-31 2023-10-24 东莞市人民医院 妊娠期糖尿病患者胎盘来源外泌体miRNA表达分析方法
GB202219102D0 (en) * 2022-12-16 2023-02-01 Univ Oxford Innovation Ltd Method
CN117647653B (zh) * 2023-12-22 2024-05-07 广州医科大学附属第三医院(广州重症孕产妇救治中心、广州柔济医院) 一种与子痫前期相关的生物标志物及其应用
EP4726057A1 (en) * 2024-10-09 2026-04-15 Universidad de los Andes In vitro method for identifying the risk of developing gestational diabetes mellitus

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005017192A2 (en) * 2003-08-14 2005-02-24 The General Hospital Corporation Screening for gestational disorders
EP1839056B1 (en) * 2004-12-21 2011-08-03 Yale University Diagnosis of preeclampsia
EP1949105A4 (en) * 2005-10-11 2009-06-17 Tethys Bioscience Inc DIABETES ASSOCIATED MARKERS AND METHOD FOR USE THEREOF
US20080300170A1 (en) * 2006-09-01 2008-12-04 Cohava Gelber Compositions and methods for diagnosis and treatment for type 2 diabetes
WO2008030273A2 (en) * 2006-09-01 2008-03-13 American Type Culture Collection Compositions and methods for diagnosis and treatment of type 2 diabetes
EP2494483A2 (en) * 2009-10-29 2012-09-05 Tethys Bioscience, Inc. Method for determining risk of diabetes
WO2014142752A1 (en) * 2013-03-12 2014-09-18 Agency For Science, Technology And Research Pre-eclampsia biomarkers

Similar Documents

Publication Publication Date Title
Labenz et al. Validation of the simplified Animal Naming Test as primary screening tool for the diagnosis of covert hepatic encephalopathy
Inoue et al. Assessment of degree of health of the stomach by concomitant measurement of serum pepsinogen and serum Helicobacter pylori antibodies
Ramanathan et al. Correlation of HVPG level with ctp score, MELD Score, ascites, size of varices, and etiology in cirrhotic patients
JP2016520192A5 (enExample)
SG179122A1 (en) Serum-based biomarkers of pancreatic cancer and uses thereof for disease detection and diagnosis
JP2015502541A5 (enExample)
Zúñiga et al. Validation of the salivary urea test as a method to diagnose chronic kidney disease
Pirhonen et al. Continuous grading of early fibrosis in NAFLD using label-free imaging: a proof-of-concept study
Quiroga et al. Diagnosis of mild platelet function disorders. Reliability and usefulness of light transmission platelet aggregation and serotonin secretion assays
JP2016521850A (ja) 脳卒中の鑑別診断を支援する方法
WO2010150254A3 (en) A method and system for the detection of cancer
JP2014505254A5 (enExample)
Shigefuku et al. Serum copeptin level is a biomarker associated with ascites retention and the formation of a portosystemic shunt in chronic liver disease
WO2010058412A1 (en) A new rapid thrombochek test kit based on whole blood screening test to detect platelet hyperaggregation at a temparature of 37°c in the clinical laboratory
Canney et al. Glomerular filtration rate-specific cutoffs can refine the prognostic value of circulating cardiac biomarkers in advanced chronic kidney disease
JP2019510974A5 (enExample)
Apica et al. Decompensated cirrhosis-related admissions in a large urban hospital in Uganda: prevalence, clinical and laboratory features and implications for planning patient management
RU2008103988A (ru) Способ диагностики рассеяного склероза
Nakov et al. Role of Fecal Calprotectin as a Noninvasive Indicator for Ulcerative Colitis Disease Activity.
JP2021510815A5 (enExample)
CN104237526B (zh) 一种检测阿兹海默症罹患风险的系统
RU2020127365A (ru) Способы, применения и комплекты для диагностики пародонтита
CN102789536B (zh) 肝脏手术治疗风险无创评估模型的建立方法
JP2008504551A5 (enExample)
JP2015528562A5 (enExample)